Therapeutic value ofalpha-4 integrin blockade in inflammatory bowel disease:the role of natalizumab

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.3, Iss.6, 2003-09, pp. : 995-1000

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natalizumab and the role of α₄-integrin antagonism in the treatment of multiple sclerosis

By O’Connor Paul

Expert Opinion on Biological Therapy, Vol. 7, Iss. 1, 2007-01 ,pp. : 123-136

Informa Healthcare

Access to resources Recommend Favorite

Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease

Current Protein and Peptide Science, Vol. 14, Iss. 4, 2013-06 ,pp. : 246-255

Bentham Science Publishers

Access to resources Recommend Favorite

Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease 1,2

By Pavlick K.P. Laroux F.S. Fuseler J. Wolf R.E. Gray L. Hoffman J. Grisham M.B.

Free Radical Biology and Medicine, Vol. 33, Iss. 3, 2002-08 ,pp. : 311-322

Elsevier

Access to resources Recommend Favorite

Alicaforsen therapy in inflammatory bowel disease

By Barish Charles F

Expert Opinion on Biological Therapy, Vol. 5, Iss. 10, 2005-10 ,pp. : 1387-1391

Informa Healthcare

Access to resources Recommend Favorite

Depleted mucosal antioxidant defences in inflammatory bowel disease

By Buffinton G.D. Doe W.F.

Free Radical Biology and Medicine, Vol. 19, Iss. 6, 1995-12 ,pp. : 911-918

Elsevier

Access to resources Recommend Favorite